The relevance of the primary prevention criteria for implantable cardioverter defibrillator implantation in Korean symptomatic severe heart failure patients

Korean Circulation Journal

Volumn 42, Issue 3, 2012, Pages 173-183

  Kim, JiYeong ^a   Choi, Eue Keun ^a   Lee, Min Ho ^a   Kang, Do Yoon ^a   Sung, Young Jun ^a   Lee, Dong Won ^a   Oh, Ilyoung ^b   Choi, Yun Shik ^b   Oh, Seil ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Death, sudden, cardiac; Heart failure; Implantable defibrillators

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PRIMARY PREVENTION; SUDDEN DEATH; SYMPTOMATOLOGY; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 84859891853     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2012.42.3.173     Document Type: Article

References (23)

1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
2. Sohn JW, Shin DG, Kim DH, et al. Non-invasive parameters, including a low left ventricular ejection fraction, for predicting sudden cardiac death in Korean post myocardial infarction patients. Korean Circ J 2006;36:431-6.
3. Vlay SC. The ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: their relevance to the cardiologist, internist and family physician. J Invasive Cardiol 2009;21:234-7.
4. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
5. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65. (Pubitemid 38496355)
6. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8. (Pubitemid 38637995)
7. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-408. (Pubitemid 351771339)
8. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-63. (Pubitemid 33043293)
9. Tanno K, Miyoshi F, Watanabe N, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005;69:19-22. (Pubitemid 40139601)
10. Siu CW, Pong V, Ho HH, et al. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients? J Cardiovasc Eleetrophysiol 2010;21:231-5.
11. Ng AC, Sindone AP, Wong HS, Freedman SB. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy. Int J Cardiol 2008;129:198-204.
12. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-8. (Pubitemid 41007844)
13. Han SW, Ryu KH, Chae SC, et al. Multicenter analysis of clinical characteristics and prognostic factors of patients with congestive heart failure in Korea. Korean Circ J 2005;35:357-61.
14. Cesario DA, Dec GW. Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol 2006;47:1507-17.
15. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
16. Sung YN, Jang SM, Lim DH, Shin SY, Song HJ, Lee SH. Prescribing Patterns of Antihypertensive Drugs by Outpatients with Hypertension in 2007. Korean J Clin Pharmacol 2009;19:167-79.
17. Remme WJ, McMurray JJ, Hobbs FD, et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J 2008;29:1739-52. (Pubitemid 352019813)
18. Doehner W, Rauchhaus M, Ponikowski P, et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005;46:1019-26. (Pubitemid 41316509)
19. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-9. (Pubitemid 38282853)
20. Ahmed A, Rich MW, Sanders PW, et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007;99:393-8.
21. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-5.
22. Mason NA, Bailie GR, Satayathum S, et al. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005;45:119-26. (Pubitemid 40038052)
23. Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol 2004;93:1124-9. (Pubitemid 38521041)